Long-term clinical prognosis of anti-aminoacyl-tRNA synthetase antibodies and interstitial lung disease

Koichi Yamaguchi, Daniel I. Sullivan, Singh Khushboo, Didem Saygin, Silvia Martinez Laverde, Siamak Moghadam-Kia, Dana P. Ascherman, Chester V. Oddis, Rohit Aggarwal

Open source

DOI
10.1007/s10067-025-07521-w
Published
2025-06-27
Container
Clinical Rheumatology
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s10067-025-07521-w,
  title = {Long-term clinical prognosis of anti-aminoacyl-tRNA synthetase antibodies and interstitial lung disease},
  author = {Koichi Yamaguchi and Daniel I. Sullivan and Singh Khushboo and Didem Saygin and Silvia Martinez Laverde and Siamak Moghadam-Kia and Dana P. Ascherman and Chester V. Oddis and Rohit Aggarwal},
  year = {2025},
  journal = {Clinical Rheumatology},
  doi = {10.1007/s10067-025-07521-w},
  url = {https://doi.org/10.1007/s10067-025-07521-w}
}

RIS

TY  - JOUR
TI  - Long-term clinical prognosis of anti-aminoacyl-tRNA synthetase antibodies and interstitial lung disease
AU  - Koichi Yamaguchi
AU  - Daniel I. Sullivan
AU  - Singh Khushboo
AU  - Didem Saygin
AU  - Silvia Martinez Laverde
AU  - Siamak Moghadam-Kia
AU  - Dana P. Ascherman
AU  - Chester V. Oddis
AU  - Rohit Aggarwal
PY  - 2025
JO  - Clinical Rheumatology
DO  - 10.1007/s10067-025-07521-w
UR  - https://doi.org/10.1007/s10067-025-07521-w
ER  - 

APA

Yamaguchi, K., Sullivan, D. I., Khushboo, S., Saygin, D., Laverde, S. M., Moghadam-Kia, S., Ascherman, D. P., Oddis, C. V., & Aggarwal, R. (2025). Long-term clinical prognosis of anti-aminoacyl-tRNA synthetase antibodies and interstitial lung disease. Clinical Rheumatology. https://doi.org/10.1007/s10067-025-07521-w

Source records